ArticleFrontiers in endocrinology2026
Increased risk of postpartum hemorrhage in women with endometriosis and adenomyosis: a prospective cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: A growing body of evidence suggests that women with endometriosis and adenomyosis are at an increased risk of complications during pregnancy and childbirth. Many of these complications are associated with increased blood loss. This study aims to evaluate and quantify the risk of postpartum hemorrhage in women with these conditions. Methods: We conducted a prospective cohort study of women with endometriosis and adenomyosis, analyzing their peripartal blood loss. Matching was performed for age and mode of conception. We defined postpartum hemorrhage as blood loss of ≥1000 mL, regardless of mode of delivery, according to the ACOG definition. Results: In our study, we examined 82 women with endometriosis and adenomyosis and 82 women without. A total of 11 women in the study group experienced postpartum hemorrhage, which is significantly higher than the rate in the control group (13% vs 1%). The unadjusted odds ratio for postpartum hemorrhage in the EM group was 8.74 (CI:2.01-82.00). The p-value was 0.002. In the adjusted analysis, participants with EM had a significantly increased risk of PPH compared to those without EM (OR:7.56, 95% CI:1.39-83.70, p=0.018), while gravidity and parity had no significant effect on the risk of PPH in our cohort. Conclusion: Our study found that women with endometriosis and adenomyosis were significantly more likely to experience postpartum hemorrhage than women without these conditions. These findings should be interpreted with caution, given the small sample size and wide confidence intervals. However, they suggest that women with endometriosis and adenomyosis may benefit from giving birth at hospitals with experience in managing postpartum hemorrhage.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.